“
“Several traditional fermented foods and beverages are produced at the household level in Burundi. These include milk products (urubu, amateregua and amavuta), cereal and banana-based beverages (Urwarwa, Isongo, Impeke and Kanyanga) and cassava-based fermented foods (Ikivunde, Inyange, Imikembe and Ubswage). Literature on Burundian fermented foods and beverages is non-existent. Therefore, the objective of this review is to document the methods by which these Burundian foods and beverages are produced and to devise scientific NU7026 in vivo means to improve their quality and optimize their production methods. (c) 2009 Elsevier Ltd. All rights reserved.”
“An updated worldwide web-based survey assessed the real-life clinical

practices regarding luteal-phase supplementation (LPS) in assisted reproduction. This survey looked for changes since a former survey conducted nearly 3 years earlier. The survey questions were: If you support the luteal phase, when do you start the regimen you are using?; Which agent/route is your treatment of choice to support the Compound C luteal phase?; If you use vaginal progesterone, which formulation do you use?; and How long you continue progesterone supplementation if the patient conceived? Data were obtained from 408 centres (82 countries) representing 284,600 IVF cycles/year. The findings were: (i) most practitioners

(80% of cycles) start LPS on the day of egg collection; (ii) in >90%, a vaginal progesterone product is

used (77% as a single agent and 17% in combination with i. m. progesterone), while human chorionic gonadotrophin AZD5363 cell line as a single agent for LPS is not being used at all; and (iii) in 72% of cycles, LPS is administered until 8-10 weeks’ gestation or beyond. When compared with the initial survey, the results of this survey are encouraging as there is a clear shift towards a more unified and evidence-based approach to LPS in IVF cycles. (C) 2013, Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.”
“Ewing sarcoma/peripheral primitive neuroectodermal tumor (EWS/pPNET) and other tumors with EWS gene rearrangements encompass a malignant and intermediate neoplasm with a broad anatomic distribution and a wide age range but a predilection for soft tissue in children, adolescents, and young adults. The overlapping histologic, immunohistochemical and cytogenetic and molecular genetic features create diagnostic challenges despite significant clinical and prognostic differences. Ewing sarcoma is the 3rd most common sarcoma in children and adolescents, and desmoplastic small round cell tumor is a rare neoplasm that occurs more often in older children, adolescents, and young adults. Pathologic examination is complemented by immunohistochemistry, cytogenetics, and molecular genetics. This article reviews the clinicopathologic features of EWS/pPNET and desmoplastic small round cell tumor in the spectrum of tumors with EWS gene rearrangements.